Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests

Diabetic Medicine

Volumn 32, Issue 5, 2015, Pages 653-656

  Tokumoto, S ^a   Hamamoto, Y ^a   Fujimoto, K ^a   Yamaguchi, E ^a   Okamura, E ^a   Honjo, S ^a   Ikeda, H ^a   Wada, Y ^a   Hamasaki, A ^a   Koshiyama, H ^a  

^a Kitano Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETATROPHIN; C PEPTIDE; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLUCAGON; INSULIN; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; ARTICLE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; GLUCAGON STIMULATION TEST; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROVOCATION TEST; AGED; BLOOD; CHEMICAL STIMULATION; COMPARATIVE STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS ISLET BETA CELL; PHYSIOLOGY; SECRETION (PROCESS); TIME FACTOR; URINE;

AGED; BIOMARKERS; C-PEPTIDE; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE HORMONES; STIMULATION, CHEMICAL; TIME FACTORS;

EID: 84928066548     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12696     Document Type: Article

References (15)

1. Yi P, Park JS, Melton DA. Betatrophin: A hormone that controls pancreatic β cell proliferation. Cell 2013; 153: 747-758.
2. Dong XY, Pang XW, Yu ST, Su YR, Wang HC, Yin YHet al. Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int J Cancer. 2004; 112: 239-248.
3. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012; 303: E334-351.
4. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012; 424: 786-792.
5. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle Eet al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 2012; 109: 19751-19756.
6. Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human beta-cell replication in the transplant setting. Diabetes 2014; 63: 1283-1288.
7. Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TMet al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014; 57: 1204-1208.
8. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia 2014; 57: 50-53.
9. Hu H, Sun W, Yu S, Hong X, Qian W, Tang Bet al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014; 37: 2718-2722.
10. Gómez-Ambrosi J, Pascual E, Catalán V, Rodríguez A, Ramírez B, Silva Cet al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocr Metab 2014; 99: E2004-2009.
11. Habener JF, Kieffer TJ. Glucagon and glucagon-like peptides. In: Kahn CR, Weir GC eds. Joslin's diabetes mellitus, 14th ed. Philadelphia: Lippincott Williams & Wilkins, 2005; 179-184.
12. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, Matsuura Tet al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 2004; 53: 831-835.
13. Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda Ket al. Analysis of factors influencing pancreatic β-cell function in Japanese patients with type 2 diabetes: Association with body mass index and duration of diabetic exposure. Diabetes Res ClinPract. 2008; 82: 353-358.
14. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285.
15. Wasén E, Isoaho R, Mattila K, Vahlberg T, Kivelä SL, Irjala K. Renal impairment associated with diabetes in the elderly. Diabetes Care 2004; 7: 2648-2653.